Should echinocandin doses be increased against Candida species? An in vitro and in vivo study of caspofungin against Candida albicans, C. krusei and C. inconspicua

被引：0
|
作者：
Kovacs, R. [1 ]
Gesztelyi, R. [1 ]
Berenyi, R. [1 ]
Doman, M. [1 ]
Kardos, G. [1 ]
Juhasz, B. [1 ]
Majoros, L. [1 ]
机构：
[1] Univ Debrecen, Debrecen, Hungary
来源：
MYCOSES | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [41] Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results
    Kardos, Tamas
    Kovacs, Renato
    Kardos, Gabor
    Varga, Istvan
    Bozo, Aliz
    Toth, Zoltan
    Nagy, Fruzsina
    Majoros, Laszlo
    JOURNAL OF CHEMOTHERAPY, 2018, 30 (04) : 233 - 239
  • [42] Antifungal Activity of Cumin Oil Against Candida parapsilosis SS25, C. orthopsilosis NN14, C. metapsilosis MP27, and C. etchellsii MP18
    Ridawati
    Jenie, Betty Sri Laksmi
    Djuwita, Ita
    Sjamsuridzal, Wellyzar
    MAKARA JOURNAL OF SCIENCE, 2011, 15 (01) : 58 - 62
  • [43] In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens
    Oezcelik, Berrin
    Kaynak, Fatma
    Cesur, Salih
    Sipahi, Bilge
    Sultan, Nedim
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2007, 60 (05) : 302 - 304
  • [44] Efficacy of in vitro antimicrobial intracanal medicaments against C. albicans and E. faecalis in primary teeth
    Rego, Emily Feitosa
    Rosario, Yedda Maria Ribeiro Vasconcelos
    Gleiser, Rogerio
    Ferreira-Pereira, Antonio
    Portela, Maristela Barbosa
    Primo, Laura Guimaraes
    BRAZILIAN ORAL RESEARCH, 2024, 38
  • [45] Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
    Jimenez-Ortigosa, Cristina
    Paderu, Padmaja
    Motyl, Mary R.
    Perlin, David S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1248 - 1251
  • [46] RETRACTED: Efficacy of Chelerythrine Against Mono- and Dual-Species Biofilms of Candida albicans and Staphylococcus aureus and Its Properties of Inducing Hypha-to-Yeast Transition of C. albicans (Retracted article)
    Qian, Weidong
    Zhang, Jianing
    Wang, Wenjing
    Liu, Miao
    Fu, Yuting
    Li, Xiang
    Wang, Ting
    Li, Yongdong
    JOURNAL OF FUNGI, 2020, 6 (02)
  • [47] Ent-hardwickiic acid from C. pubiflora and its microbial metabolites are more potent than fluconazole in vitro against Candida glabrata
    Sousa Teixeira, M., V
    Fernandes, L. M.
    de Paula, V. Stefanelli
    Ferreira, A. G.
    Jacometti Cardoso Furtado, N. A.
    LETTERS IN APPLIED MICROBIOLOGY, 2022, 74 (04) : 622 - 629
  • [48] Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against Candida albicans Infections: An In Vitro and In Vivo Study
    Fenley, Juliana de C.
    de Barros, Patricia P.
    do Carmo, Paulo H. F.
    Garcia, Maira T.
    Rossoni, Rodnei D.
    Junqueira, Juliana C.
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (11) : 5379 - 5389
  • [49] Evaluation of (-)-Fenchone antimicrobial activity against oral Candida albicans and toxicological parameters: an in silico, in vitro and ex vivo study
    Dos Santos, Andre A.
    De Oliveira-Filho, Abrahao A.
    Teixeira, Braulio A.
    Galvao, Jose Lucas F. M.
    de Medeiros, Maria Alice A.
    Alves, Millena S.
    Barbosa, David Henrique X.
    Mafra, Rodrigo P.
    Vasconcelos, Ulrich
    Lima, Edeltrudes O.
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2024, 96 (04):
  • [50] In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C-glabrata in a neutropenic murine candidiasis model
    Andes, D. R.
    Diekema, D. J.
    Pfaller, M. A.
    Marchillo, K.
    Bohrmueller, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) : 3497 - 3503
12345